《中华肾脏病杂志》投稿须知

合集下载

中华肾脏病年会2021文章录用

中华肾脏病年会2021文章录用

中华肾脏病年会2021文章录用
由中华医学会、中华医学会肾脏病学分会主办,海南省医学会承办的中华医学会肾脏病学分会20xx年学术年会受xx影响于20xx年x月x日在海南省海口市海南国际会议展览中心以线上线下结合的方式举行。

在本次中华医学会肾脏病学术年会的论文征稿中,xx市人民医院肾内科血液净化室医护团队以丰富的肾脏病临床经验参与论文投稿,共有来自李聃丹副主任医师和蒲锐副主任护师的2篇论文被录取参加年会交流。

中华医学会肾脏病学分会学术年会是中国肾脏病领域规模最大、水平最高的学术盛会,为从事肾脏病学临床和科研的医务工作者及专职科研人员了解肾脏病学研究动态和最新进展、加强国内外学术交流、培养和提高临床思维及科研能力、改进肾脏病学医疗服务质量和水平提供良好的平台。

同时,也为广大医护人员学习现代肾脏病诊疗知识、相互交流与合作提供了极好的机会。

xx市人民医院血液净化室不仅拥有优良的透析设施,技术精湛、经验丰富的医护人员,更注重医护人员日常学习及提升成长。

在科室陈xx主任带领下,李xx副主任医师《xx地区慢性肾脏病5期患者首次血液透析情况的研究》及蒲x副主任护师《分段式健康教育在围透析期患者中的应用》共计两篇学术论文入选中华医学会肾脏病学学术年会,更展示了中心医护人员潜心血液透析专科研究的丰硕成果。

原定这两位老师届时荣誉出席大会加强交流、学习、总结,以反哺科室医疗、护理与科研工作,但受突发xx影响,两位老师将继续坚守岗位、扛起责任,参与家乡xx防控,并在线上继续学习,不断总结科研与临床成果,不断前行。

《中华医学》杂志投稿须知

《中华医学》杂志投稿须知

《中华医学杂志》简介《中华医学杂志》(ISSN 0376-2491, CN 11-2137/R) 创刊于中华医学会成立的1915年。

创刊之初是中、英文双语期刊,英文刊名为National Medical Journal of China 。

1932 年,《中华医学杂志》的英文部分与中国博医会的英文杂志China Medical Journal (博医会报)合并,以Chinese Medical Journal 为刊名出版;中文部分仍称《中华医学杂志》继续出版,并继续保留National Medical Journal of China 的英文刊名,现在,在中华医学杂志的论著类文章中依然保留英文的作者姓名、通讯地址和严格的英文摘要。

作为中国卫生部中华医学会的会刊、中华医学会主办的一本医学综合性学术期刊,中华医学杂志创刊90年来始终坚持以服务广大会员和医药卫生科技人员、促进国内外医学学术交流和医学事业发展为宗旨,全面反映中国医学最新的科研成果,紧密跟踪世界医学科技进步的潮流,理论与实践结合,提高与普及并重,积极推广医药卫生领域的新技术、新成果,及时交流防病治病的新经验,大力普及医学科技新知识,为提高中国广大医药卫生人员的思想和职业道德修养、医学科学理论和业务技术水平,推动中国医学科技进步和知识创新,以及繁荣中国医学科技出版事业,发挥了重要作用。

历经数代人的努力,《中华医学杂志》形成了科学性强、权威度高、影响力大、覆盖面广的刊物特色,树立了良好的社会形象,在中国医学界享有很高的声誉。

中国国家图书馆、中国科技信息研究所、中国医学科学院科技信息研究所、中国科学文献计量评价研究中心等国家科技信息情报部门均把中华医学杂志列为核心期刊。

据中国科技论文与引文数据库和中国科学引文数据库提供的资料,中华医学杂志的被引频次连续数年在中国医学期刊中位居前十名(由《中国科技期刊引证报告》,2003 年是医学类第五名,2004 年是医学类第三名),影响因子连续五年呈上升趋势,在综合类医学期刊中始终位居前五名(由《中国科技期刊引证报告》,2003 年是医学综合类第三名,2004 年是医学综合类第四名)。

《中华检验医学杂志》网上投稿须知《中华检验医学杂志》网上投稿须知

《中华检验医学杂志》网上投稿须知《中华检验医学杂志》网上投稿须知

《中华检验医学杂志》投稿须知期刊简介:中华检验医学杂志为中华医学会主办的检验医学专业学术期刊,以广大中高级检验医学人员和临床医师为主要读者对象,报道我国检验医学领域领先的科研成果。

本刊的办刊宗旨是贯彻党和国家的卫生工作方针政策,贯彻理论与实践相结合的方针,反映我国检验医学科研工作的重大进展,促进国内外检验医学学术交流。

刊名:《中华检验医学杂志》,英文:《Chinese Journal of Laboratory Medicine》主办单位:中华医学会。

编辑单位:北京市东四西大街42号《中华检验医学》杂志编辑部。

地址:北京市朝阳区十里堡甘露西园1号楼314室。

邮政编码:100710。

电子邮件:zhjyyxzz@ 。

国际刊号:1009-9158。

国内刊号:11-4452/R。

期刊种类:月刊。

栏目设置:本刊设有述评、专家论坛、新进展、论著、科研快讯、会议纪要、管理、综述、讲座、继续教育园地、争鸣与讨论、国内外学术动态等栏目。

欢迎踊跃投稿,来稿经专家审核后择优刊用。

一、投稿要求和注意事项1、投稿方式。

电子邮件投稿(即网络投稿)请用Word格式的附件来邮;邮寄来稿请尽量用小四号字打印在A4纸上,凡字迹潦草、涂改不清的稿件,恕不受理。

来稿须附单位推荐信(电子邮件投稿请拍照后以JPG格式的附件来邮),作者单位对文稿的真实性和保密性负责,并声明未一稿两投、不涉及保密、署名无争议等项,并注明第一作者姓名、性别、学历、职称、职务、单位、地址及邮码务必写清楚。

多作者稿署名时须征得其他作者同意,排好先后次序,接《稿件录用通知书》后不再进行改动。

为加快稿件处理速度、提高工作效率,条件允许的作者请尽量优先选择电子邮件的方式投稿,本刊全国统一投稿电子邮箱:zhjyyxzz@ 。

请作者尽量勿选择邮寄稿件,以免遗失或延误时间。

热忱欢迎广大读者踊跃投稿和订阅。

2、稿件沟通。

来稿一经接受刊登,有关稿件沟通事宜,编辑部均与第一作者或通讯作者通过电子邮件方式进行联系,作者接收本刊《来稿录用通知书》后,由第一作者或通讯作者通过回复电子邮件方式,进行同意稿件在本刊发表的授权意愿。

电子邮件投稿注意事项

电子邮件投稿注意事项

5. 赵徐榕ꎬ黄新宇ꎬ骆乐. 黄芪桂枝五物汤佐治老年糖尿病肾病
杨洪涛 [18] 运用经方辨治慢性肾脏病 4 则提到黄芪桂枝五物汤
6. 孙怡. 黄茂桂枝五物汤加减治疗糖尿病肾病的临床观察. 中
芍 10 g、大枣 4 枚、生姜 15 g、酸枣仁 30 g、生龙骨 30 g、煅牡蛎
7. 李华ꎬ赵影ꎬ李江菊. 中医药治疗糖尿病肾脏微循环障碍. 中
黄芪桂枝五物汤经方新用ꎬ既是中医文化的传承ꎬ又是经
方临床应用的创新ꎬ在肾脏疾病治疗中ꎬ不仅具有很好的临床
治疗效果ꎬ而且还有极高的安全性ꎬ值得我们进一步推广ꎮ
参 考 文 献
1. 侯卫国ꎬ高建东ꎬ关新ꎬ等. 黄芪桂枝五物汤治疗脾肾阳虚型
性肾衰竭的疗效研究. 中医药导报ꎬ2015ꎬ14(21) :76 - 77.
临床效果. 医疗装备ꎬ2018ꎬ21(18) :105 - 106.
16. 王付. 黄芪桂枝五物汤合方应用探讨. 中医药通报ꎬ2011ꎬ
(3) :24 - 26.
17. 王樟月. 黄茂桂枝五物汤治疗特发性水肿 38 例. 浙江中医
杂志ꎬ2006ꎬ41(17) :47 - 50.
18. 杨波ꎬ李洁ꎬ李康ꎬ等. 杨洪涛运用经方辨治慢性肾脏病验案
1128
中国中西医结合肾病杂志 2019 年 12 月第 20 卷第 12 期 CJITWNꎬDecember 2019ꎬVol. 20ꎬNo. 12
展至肾脏终末期ꎬ提高总体有效率ꎮ 慢性肾衰竭病机多属脾肾
虚衰夹瘀ꎬ表现出“ 正虚受邪” 的病机特点ꎬ黄芪桂枝五物汤通
早期 32 例疗效观察. 浙江中医杂志ꎬ2016ꎬ17(4) :259.
国中西医结合肾病杂志ꎬ2000ꎬ1(4) :11 - 12.

电子邮件投稿注意事项

电子邮件投稿注意事项

电子邮件投稿注意事项
本刊编辑部
【期刊名称】《中国中西医结合肾病杂志》
【年(卷),期】2022(23)8
【摘要】为了加快本刊时效性,欢迎广大读者通过电子邮件投稿。

本刊邮箱地址:*****************。

作者通过电子邮件投稿后请注意以下事项:(1)邮寄单位证明材料1份,注明有无一稿两投、有无署名争议、是否涉及保密等内容;(2)邮寄纸质稿件1份,以小4号字、1.5倍行距,A4纸打印;(3)请邮寄审稿费人民币50元整;(4)请留详细联系电话,以便有关稿件事宜及时与您联系。

此外,请经常查收您的邮箱,以便第一时间获取稿件回执以及稿件处理等相关信息。

【总页数】1页(P673-673)
【作者】本刊编辑部
【作者单位】不详
【正文语种】中文
【中图分类】TP3
【相关文献】
1.电子邮件投稿注意事项
2.电子邮件投稿注意事项
3.电子邮件投稿注意事项
4.电子邮件投稿注意事项
5.电子邮件投稿注意事项
因版权原因,仅展示原文概要,查看原文内容请购买。

肾脏病学有哪些较好的杂志

肾脏病学有哪些较好的杂志

肾脏病学有哪些较好的杂志肾脏病是一种严重危害人类健康常见病的统称,主要包括不同类型的肾炎、急性肾衰竭、肾结石、肾囊肿等等。

肾脏病学在内科学中是一个相对比较年轻的学科。

因肾脏繁杂的生理功能及其特有的组织结构特点使它在多种情况下易罹患损伤。

那么肾脏病学有哪些较好的杂志呢?《中华肾脏病杂志》(月刊)创刊于1985年,由中华医学会主办。

以反映我国肾脏病领域的研究成果与进展,报道国内外有关的学术活动为主要办刊宗旨。

及时报道肾脏病的研究领域经验丰富的科研成果和临床诊疗经验,对促进本学科研究和临床应用有很大的价值。

遵循基础与临床相结合、普及与提高相并重的办刊原则,为广大读者提供及时、实用的肾脏病新进,努力促进国内外学术交流。

读者对象和范围为国内儿科尤其是肾脏病专业的医师、医学科研工作者、高校教师以及研究生。

《肾脏病与透析肾移植杂志》(双月刊)创刊于1992年,由南京大学医学院解放军肾脏病研究所主办。

是专业学术性期刊。

以交流推广肾脏病学、透析及肾移植方面的科研成果和临床实践经验,推动我国肾脏病学的发展为己任。

设有述评、论著、学术快讯、论著摘要、基础医学、医学继续教育、肾脏病基础与临床、血液净化、肾脏移植、肾活检、实验室方法、学术争鸣等栏目。

本刊为科技期刊统计源、核心期刊,为各种数据库和检索期刊收为信息源。

为业内专业技术人员和大专院校师生重点阅读刊物。

《中国中西医结合肾病杂志》是由中国中西医结合学会主办、在国内外公开发行的国家级学术期刊。

以促进国内外肾脏病的中西医结合学术交流为宗旨,报道西医、中医、中西医结合的新成就、新理论和新技术、开展学术争鸣与交流。

设有著名专家论病、名医经验荟萃、临床论著、实验论著、短篇论著、专病专方、经验交流、讲座与综述、病例报道等栏目。

读者对象为内科、肾内科、儿科、妇产科、中医科、泌尿科等的科研、教学及医务人员。

《临床肾脏病杂志》创刊于2001年,是由湖北省科学技术协会主管,中华医学会武汉分会、湖北省微循环学会主办的专业性学术刊物。

《临床肾脏病杂志》稿约

《临床肾脏病杂志》稿约

《临床肾脏病杂志》稿约
佚名
【期刊名称】《临床肾脏病杂志》
【年(卷),期】2024(24)3
【摘要】《临床肾脏病杂志》是由湖北省科学技术协会主管,中华医学会武汉分会.湖北省微循环学会主办,国内外公开发行的肾脏病专业性学术刊物。

本刊为中国科技论文统计源期刊(中国科技核心期刊),自2004年起,被国家科技部中国科技论文与引文数据库(CSTPCD)收录。

2008年起变更为月刊。

本刊以从事肾脏病专业的科研、教学与临床工作者为主要读者对象:以服务于读者、促进国内外医学学术交流和医掌科学发展,提高全民健康水平为宗旨。

本刊实行同行审稿制度,采用网络化审稿。

本刊的办刊方针是理论与实践相结合,普及与提高相结合.积极倡导百花齐放.百家争吗。

【总页数】2页(PF0002)
【正文语种】中文
【中图分类】G23
【相关文献】
1.《临床肾脏病杂志》稿约
2.《临床肾脏病杂志》稿约
3.《临床肾脏病杂志》稿约
4.《临床肾脏病杂志》稿约
5.《临床肾脏病杂志》稿约
因版权原因,仅展示原文概要,查看原文内容请购买。

中华医学杂志英文版投稿须知

中华医学杂志英文版投稿须知

Instructions for authorsChinese Medical Journal (CMJ) is an international, peer-reviewed general medical journal published in English semimonthly by the Chinese Medical Association and distributed worldwide. Manuscripts are welcome from any part of the world.MANUSCRIPT INFORMATIONManuscript requirementsManuscripts submitted to CMJ should meet the following criteria: the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data.Manuscript submissionAuthors are required to submit their manuscripts online at .Previous publication or duplicate submissionManuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of possibly duplicative materials that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.Previous presentationA complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) can be considered.CATEGORIES OF ARTICLESCMJ publishes editorial, original article, review article, medical progress, brief report,viewpoint, case report, letter, and many other categories of articles. Topics of interest include all subjects that relate to the practice of medicine and research.EditorialThese are usually commissioned, however, unsolicited editorials are welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials should be up to 2000 words long with no more than 25 references.Original articleManuscripts on epidemiological studies, studies of social medicine, clinical trials, especially large scale randomized controlled trials are welcome. Each manuscript should clearly state an objective or hypothesis, the methods, the main results of the study and the conclusions. The length is limited to 2000–4000words (not including tables, figures, and references).More than 20 references are encouraged to be cited in this kind of articles.Meta analysisOnly results of meta analysis are reported in this kind of article. The length of the article is within 2000–4000 words (not including tables, figures, and references). Medical progressThis kind of article is mainly solicited, but we also consider unsolicited articles. The length of the article is within 2000–4000 words (not including tables, figures, and references).Review articleReview articles include systematic, critical assessments of literature and data sources pertaining to different medical topics, such as cause, diagnosis, prognosis, therapy, or prevention, etc.The length is limited to 2000–4000words (not including tables, figures, and references).Brief reportThese articles are short reports of original studies. They should not exceed 2500 words with no more than 2 tables and/or two illustrations and 15 references.Clinical experienceAuthors of these articles provide their experiences for diagnosis, treatment or prevention of diseases. The length is up to 2500 words with no more than 2 tables and/or two illustrations and 15 references.ViewpointPersonal views are welcome and the length should be 1000–3000 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.Case reportAuthors usually describe one to three patients or a single family. The text is limited to no more than 2500 words, and up to 15 references.Clinical solutionsThe articles are evidence-based reviews of topics relevant to practicing physicians. Articles in this series should include the following sections: case report, clinical overview, strategies, clinical difficulties, and author’s personal opinions. The text is limited to 3000 words and a small number of figures and tables. Images for diagnosisAuthors can provide here with typical images of common or uncommon medical conditions. This feature is intended to capture the sense of visual discovery and variety that physicians experience. It is not intended as a vehicle for case reports.LetterLetters to editors discussing a recent CMJ article should be received within 3 months of the article’s publication and should not exceed 500 words of text and 5 references. Letters should also be submitted online.AUTHOR INFORMATIONDesignate a corresponding author and provide a complete address,telephone and fax numbers, and E-mail address.Authorship requirementsEach author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based on(1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.Conditions 1, 2, and 3 must all be met.1Group authorshipIf authorship is attributed to a group, all members of the group must meet the full criteria and requirements for authorship as described above. A group must designate at least one individual as corresponding author. Other group members may be listed in an Acknowledgment.Conflicts of interestAuthors should indicate relevant conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their covering letter. Authors without relevant financial interests in the manuscript should indicate no such interest.EDITORIAL REVIEW AND PUBLICATIONPeer reviewA CMJ editor reviews submitted manuscripts initially. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential.The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Rejected manuscriptsRejected manuscripts and reasons for rejection can be found online. EditingAccepted manuscripts are copyedited first by native speakers and then by CMJ editors according to CMJ style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the editor and authorized by the corresponding author.PublicationAuthors are required to pay page fee if their manuscripts are accepted for publication. The publisher will provide the author (s) 2 copies of the journal free of charge.CopyrightThe Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of the Chinese Medical Association and may not be published elsewhere without written permission. Chinese Medical Association keeps the right to use these manuscripts in any form, including print, video, audio, and digital.MANUSCRIPT PREPARATIONManuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the International Committee of Medical Journal Editors (ICMJE) ().Submit the original manuscript online; use 1 side of standard-sized page and 1.5 cm margins.For Chinese authors, submission of a Chinese version of the manuscript (or abstract) is recommended.Use only 10- or 12-point font size.On the title page include the full names and affiliations of all authors. If an author’s affiliation has changed since the work was done, list the new affiliation as well. Titles should be concise and descriptive. The name, address, telephone number, fax number, and E-mail address of the correspondence author should be addressed. Any grant support that requires acknowledgment should be mentioned on this page.Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury. All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System Units (SI).Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.Do not use abbreviations in the title or abstract and limit their use in the text.A covering letter signed by all authors includes(1) information on prior or duplicate publication or submission elsewhere of any part of the study; (2) the statement that the manuscript has been read and approved by all the authors and that the criteria for authorship have been met; (3) the statement on financial or other conflict of interests; and (4) any suggestions such as referring possible unqualified reviewers due to conflict of interests, etc. The corresponding author must sign the acknowledgment statement. Authors should obtain written permission from all individuals named in an acknowledgment.JOURNAL STYLETablesTables should be simple and no duplicate information should appear in the text of the article. Tables should be numbered consecutively, and headed by a concise title. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Forfootnotes use the following symbols in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡.FiguresComplete sets of illustrations must be submitted with legends typed on the same page. Only clear photographs are acceptable. All lettering must be legible after reduction to column size. Magnification and staining should be indicated when pertinent. AbbreviationsUse only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.Ethical requirementFor experimental investigations of human subjects, state in the Methods section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees,the principles outlined in the Declaration of Helsinki2 should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants.Patient descriptions, photographs, and pedigreesInclude a signed statement of informed consent to publish (in print and online) patient descriptions, photographs, and pedigrees from all persons (parents or legal guardians for minors) who can be identified in such written descriptions, photographs, or pedigrees. Such persons should be shown the manuscript before its submission.Permissions required to reproduce or adapt material Acknowledge all text, illustrations, and tables adapted or reproduced from other publications and submit permission from the original publishers(or other copyright owner) to republish in print, online, and licensed versions of CMJ.ReferencesNumber references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references,abbreviate titles of journals according to Medline. Note: List authors and/or editors up to 6; if more than 6, list the first 6 authors followed by et al.Examples of reference style:1. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein a blation: What’s the difference? Chin Med J 2005; 118: 1773-1778.2. Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm. Chin J Obstet Gynecol (Chin)* 1998; 33: 113-114.3. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.4. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.5. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97.6. Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32 (Pt 3): 303-306.7. Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.8. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. (Accessed April 9, 2003 at http://www.who.int/csr/sarscountry/ 2003_04_04/en/.)*: It is especially needed to note “(Chin)” for articles published in Chinese.Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.REPORT OF ORIGINAL DATAAbstractInclude a structured abstract of no more than 300words for original articles, meta analysis, brief report, clinical experience (Background, Methods, Results, Conclusions) and review articles (Objective, Data sources, Study selection, Results, Conclusions); an informative abstract for medical progress, viewpoint, case report, clinical solutions and images for diagnosis.KeywordsThree to 6 words or short phrases should be provided at the top of the abstract page as keywords. Terms from the medical subject heading (MeSH) list of Medline should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.IntroductionIntroduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.MethodsDescribe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.Iden tify the methods, apparatus (list the manufacturer’s name and original country in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate theirlimitations. Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.Reports of randomized clinical trials should present information on all major study elements including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors are recommended to refer to the CONSORT Statement 3 for details.ResultsOverall describe the major findings of the study. Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. DiscussionSummarize the major findings. Discuss possible problems with the methods used. Compare your results with previous work. Discuss the clinical and scientific (if any) implications of your findings and their limitations. Suggest further work. Produce a succinct conclusion.MANUSCRIPT CHECKLISTSubmit complete text of your manuscript online (including tables, figures, etc), in addition, domestic authors should submit Chinese version of the complete text or its abstract.Review the sequence: covering letter, title page, key words and abstract, text, acknowledgments, references, tables, legends for illustrations.Check all references for accuracy and completeness. Put references in proper format in numerical order, making sure each is cited in the text.Include written permission from each individual identified as a source for personal communication.Include informed consent forms for identifiable patient descriptions, photographs and pedigrees.Keep copies of everything submitted.Manuscript inquiriesTel:86-10-85158321.Fax:86-10-85158333.Email:***********. cn.REFERENCES1.International Committee of Medical Journal Editors. Uniformrequirements for manuscripts submitted to biomedical journals.(Accessed September 10, 2009 at: )2.World Medical Association. Declaration of Helsinki: Ethicalprinciples for medical research involving human subjects.(Accessed September 6, 2005 at: /e/policy/ pdf/ 17c.pdf)3.Schulz KF, Altman DG, Moher D, for the CONSORT Group.The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (Accessed October 28, 2010 at: http://www.consort- )。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

《中华肾脏病杂志》投稿须知
信息来源:作者:发布时间:2015-1-17
《中华肾脏病杂志》是由中国科学技术协会主管,中华医学会主办,为我国内、儿科肾脏病学科领域最高水平的专业期刊,中山大学出版并向国内外公开发行的肾脏病学的专业学术期刊,同时也是中华医学会肾脏病学分会的专业性学术期刊。

对促进肾脏病学术交流及发展起着重要的指导作用。

中国科技期刊引证报告显示,本刊被引频次和影响因子均名列同类杂志之首,已成为国内较有影响力的核心期刊之一。

《中华肾脏病杂志》创办于1985年,月刊,规格为国际通用的大16开本,由《中华肾脏病杂志》编辑委员会编辑,中华肾脏病杂志编辑部出版,国际标准刊号ISSN1001-7097,国内统一刊号CN44-1217/R,邮发代号:46-106,单价:12.00,全年定价:144.00。

《中华肾脏病杂志》是国内肾脏病领域学术影响力和发行量最大的期刊。

现为全国中文核心期刊(北大1992、1996、2000、2004、2008版中文核心期刊目录(医药卫生类)),
是中国科技论文统计源期刊(2008年版中国科技论文统计源期刊),已被CA 化学文摘(美)(2009),CBST 科学技术文献速报(日)(2009),中国科学引文数据库(CSCD—2008)数据库和检索系统收录。

1.论著一般不超过5000字(包括摘要、图表及参考文献);讲座、综述、会议纪要、临床病理(例)讨论类文稿字数可视具体情况而定;短篇论著(论著摘要)、病例报告等不超过2000字。

2.推荐信:来稿需经作者单位审核,并附单位推荐信。

推荐信应注明对稿件的审评意见以及无一稿两投、不涉及保密、署名无争议等项,并加盖公章。

如涉及保密问题,需附有关部门审查同意发表的证明。

3.投稿清单:(1)单位介绍信(推荐信)、医学伦理知情同意书;(2)题名及作者,作者单位,基金资助项目,项目负责人,Email,电话,传真,投稿日期;(3)中文摘要;(4)英文摘要;(5)正文:引言,材料与方法,结果,讨论,志谢,参考文献(视文章体裁选择相关项目)。

4. 投稿方式:从2007 年1月起,本刊将启用电子投稿:zhszbqk@,全面试行网上投稿、网上审稿、网上查询等方面的工作。

欢迎广大作者进行投稿和查询。

电子版:为了便于专家网上操作,同时需要提供文章的电子版(远程或E-mail )。

电子版要注意查看下大小,如果超过5M,建议分部分发送到编辑部邮箱;如果特大,则建议对高分辨率图片进行一定的压缩,具体压缩方式为:首先图片要粘贴到Word里面,鼠标点图片,右键,设置图片格式,左下角有个“压缩”,点击它就可以把10几个M的图片压缩为几百K。

对于有高要求的图片,建议刻录光盘寄送到编辑部。

发E-mail时,务必要注明作者姓名,有稿号时也要注明稿号,每天邮件较多,这样可以方便查找。

5.医学伦理问题及知情同意:当论文的主体是以人为研究对象时,作者应说明其遵循
的程序是否符合负责人体试验的委员会(单位性的、地区性的或国家性的)所制订的伦理学标准,并提供该委员会的批准文件及受试对象或其亲属的知情同意书。

6.基金项目:论文所涉及的课题如为国家或部、省级以上基金或攻关项目,应在文章首页地脚以“基金项目:”作为标识注明基金项目名称,并在圆括号内注明其项目编号。

基金项目名称应按国家有关部门规定的正式名称填写,多项基金应依次列出,其间以“;”隔开。

如“基金项目:国家自然科学基金(30271269);“十五”国家高技术研究发展计划
(2003AA205005 )。

”作为脚注的第一项,并须附基金项目证明复印件。

7.根据《中国人民共和国著作权法》,并结合本刊实际情况,凡接到本刊收稿回执后3个月内未接到稿件处理通知者,系仍在审阅中。

作者如欲投他刊,请先与本刊联系,切勿一稿两投。

一旦发现一稿两投,将立即退稿;而一旦发现一稿两用,本刊将进行如下处理:(1)刊登撤销该论文及该文系重复发表的声明,并在中华医学会系列杂志上通报;(2)向作者所在单位和该领域内的其他科技期刊进行通报;(3)2年内拒绝发表以该文第一作者为作者的任何来稿。

已在非公开发行的刊物上发表,或在学术会议交流过,或已用其他文种发表过(需征得首次刊登期刊的同意)的文稿,不属于一稿两投,但作者在投稿时必须注明。

已在一种杂志以摘要形式发表的论文可将全文投给其他杂志。

8.作者对来稿的真实性及科学性负责。

依照《中华人民共和国著作权法》的有关规定,本刊可对来稿做文字修改、删节。

凡有涉及原意的修改,则提请作者考虑。

修改稿逾期2
个月不寄回者,视作自动撤稿。

9.作者在投稿及修稿时,应明确作者及其顺序,有通讯作者的应注明,刊出时左下脚的通讯作者不能和第一作者相同,如果相同编辑部将删除,并不另行通知。

关于作者的相关问题如果改动必须提供书面的资料,以供编辑部备案。

相关文档
最新文档